MENU

Can HIVE Digital Technologies (HIVE) Stock Reach $7?

a developer of cloud networking and enterprise Wi-Fi solution

HIVE
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
Oct 21, 2026

Can HIVE Digital Technologies (HIVE) Stock Reach $7?

HIVE Digital Technologies Ltd., a green-energy Bitcoin mining and high-performance computing (HPC) company, has endured a steep drawdown from its 52-week high of roughly $6.30. With the stock trading near $1.98, the question on many investors' minds is whether it can rebuild toward the $7.00 level that dominates much of the current sell-side coverage.

Key Takeaways

  • The central $7.00 stock price target is the arithmetic mean of current analyst price targets (calculated at roughly $6.90), rounded to a clean level.
  • Verified analyst price targets span a wide range, from about $4.50 to $10.00, reflecting sharply divided views on the company's outlook.
  • At a latest price near $1.98, reaching $7.00 would require a gain of roughly 250% — a very large move.
  • The strongest supports are the expanding AI/HPC (BUZZ) business and a recent $350 million GPU cloud contract, alongside Bitcoin mining scale.
  • The biggest risks are persistent losses, Bitcoin price volatility, execution and financing needs, and continued insider selling.

Analyst Price Targets and Consensus View

The current analyst price targets are unusually dispersed, which is typical of Bitcoin-linked equities whose fortunes track cryptocurrency prices. Reviewed targets range from approximately $4.50 (Cantor Fitzgerald, Overweight) to $10.00 (Canaccord Genuity, Buy, most recently reaffirmed in October 2026). In between sit HC Wainwright at $7.00 (Buy), Chardan Capital at $7.50 (Buy), B. Riley at $8.00 (Buy), Rosenblatt at $6.00 (Buy), and Keefe, Bruyette & Woods at $5.00 (Market Perform).

Averaging these verified, current targets yields roughly $6.90, which rounds to the $7.00 central target used throughout this article — essentially in line with the $6.95 consensus tracked independently by MarketBeat. The divergence among analysts matters: bulls emphasize recurring AI revenue, while the more cautious firms focus on valuation and Bitcoin exposure. Notably, Weiss Ratings and Wall Street Zen have carried sell ratings on the shares, underscoring that this is not a uniformly bullish setup.

Current Market Position and Path Toward the Target

The stock last traded near $1.98, close to its 52-week low of $1.73 and far below the $6.30 high. A move to $7.00 therefore implies upside of about 250%, which must be described as very large rather than modest. HIVE's market capitalization is roughly $550 million, and the company carries a beta near 3.8, meaning its shares are considerably more volatile than the broader market.

The plausible path toward the target rests on a dual narrative: sustained or rising Bitcoin prices lifting mining economics, combined with the HPC segment scaling into a predictable, recurring revenue stream. HIVE reported fiscal first-quarter 2027 revenue of $79.1 million (up about 74% year over year) but still posted a net loss, with EPS (earnings per share) of -$0.54, below consensus expectations. A credible move toward $7.00 would likely require the market to begin valuing the stock on its growing HPC backlog rather than on current mining cash flows.

What Could Support a Move Toward the Target

  • The BUZZ HPC subsidiary signed a five-year, roughly $350 million GPU cloud agreement with an investment-grade customer, adding about $70 million in annualized revenue and lifting total BUZZ annualized revenue toward $180 million.
  • HIVE operates at meaningful Bitcoin mining scale — more than 2% of global network hashrate at times — and mined 2,311 BTC in 2025, up 31% despite rising difficulty.
  • Management is guiding HPC/AI annual recurring revenue higher and expanding GPU capacity, which could reduce reliance on volatile mining income.
  • Recent analyst actions have been constructive, with B. Riley, Rosenblatt, and KBW all raising targets through mid-2026 after earlier cuts.

What Could Prevent the Target From Being Reached

  • HIVE remains unprofitable, with a negative net margin near 98% in the latest quarter, and its losses have repeatedly exceeded consensus estimates.
  • The stock's valuation and revenue are tightly linked to Bitcoin prices; a sustained crypto downturn would compress mining revenue and sentiment.
  • Building out GPU capacity requires substantial capital, and execution or financing shortfalls could delay the AI revenue ramp.
  • Insiders, including the COO and a director, sold shares through 2026, which some investors read as a caution signal.
  • Competition in both Bitcoin mining and AI cloud hosting is intense, and the company's high beta amplifies downside in risk-off markets.

Technical Levels and Market Structure

HIVE is trading below its 50-day and 200-day moving averages, which sit in the high $2 and low $3 range, respectively — a bearish long-term structure. Durable support is the 52-week low near $1.73, with the $2.00 psychological level serving as a nearer reference. On the upside, the prior high around $6.30 is the most significant resistance zone, and the $7.00 target would require clearing that former peak entirely. Until the stock reclaims its longer-term averages, the technical picture remains defensive.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a roughly 12-month research horizon, though no single timeline was stated across the firms reviewed. Investors should watch quarterly earnings and EPS trends, updates on the $350 million GPU contract and HPC annualized revenue, Bitcoin price movements and network difficulty, and any further analyst target revisions. Company-specific items such as financing announcements and insider transactions also carry weight, given HIVE's capital needs.

AI Daily Buy/Sell Signals

For traders seeking a more systematic view of HIVE's shifting momentum, Tickeron's AI Daily Buy/Sell Signals offer a useful complement to fundamental research. The platform uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. This can help traders discover opportunities, monitor existing positions, and spot emerging trends more efficiently than manual screening alone. Those interested in adding an AI layer to their HIVE analysis may find the signals a practical starting point.

Final Assessment

Whether HIVE can reach $7.00 depends on a convergence of crypto strength and successful AI infrastructure execution. The target reflects the average analyst price target near $6.90, rounded to $7.00, with a wide range of $4.50 to $10.00 that signals genuine disagreement. The roughly 250% move required is very large and would mean fully recovering from the stock's steep decline and pushing beyond its prior high. The $350 million GPU contract and expanding HPC revenue provide a credible, if unproven, growth engine, while ongoing losses, Bitcoin dependence, and financing risk remain the principal obstacles. No outcome is assured, and investors should treat the target as a research reference rather than a forecast.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
HIVE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

HIVE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HIVE has been closely correlated with CLSK. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if HIVE jumps, then CLSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIVE
1D Price
Change %
HIVE100%
-3.94%
CLSK - HIVE
77%
Closely correlated
-6.86%
KEEL - HIVE
76%
Closely correlated
-6.67%
CIFR - HIVE
73%
Closely correlated
-8.87%
BTBT - HIVE
73%
Closely correlated
-3.73%
COIN - HIVE
73%
Closely correlated
-4.51%
More

Groups containing HIVE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIVE
1D Price
Change %
HIVE100%
-3.94%
HIVE
(8 stocks)
73%
Closely correlated
-3.30%